Advertisement
Canada markets open in 3 hours 7 minutes
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7311
    +0.0013 (+0.18%)
     
  • CRUDE OIL

    82.78
    -0.03 (-0.04%)
     
  • Bitcoin CAD

    86,966.95
    -3,819.09 (-4.21%)
     
  • CMC Crypto 200

    1,360.23
    -22.34 (-1.62%)
     
  • GOLD FUTURES

    2,337.60
    -0.80 (-0.03%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,504.00
    -160.50 (-0.91%)
     
  • VOLATILITY

    16.14
    +0.17 (+1.06%)
     
  • FTSE

    8,092.06
    +51.68 (+0.64%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6812
    -0.0007 (-0.10%)
     

What Does NovoCure’s Valuation Trend Indicate?

What Does NovoCure’s Valuation Trend Indicate?

NovoCure’s (NVCR) net financial expenses increased from $2.18 million in the second quarter of 2017 to $2.86 million in the second quarter. NovoCure’s income tax expenses also increased from $3.46 million in the second quarter of 2017 to $5.56 million in the second quarter.